COMMUNIQUÉS West-GlobeNewswire

Loos, France, RLG Headquarter, January 15th 2019: Radiopharma Logistics Group (RLG); Isotopes Service International restructuring successfully completed, 11 Million treated patients, thanks to RLG in 2018.

16/01/2019 - 14:00

Acquired by Isovital in sept 2017 while it was in a complex situation, the Belgian company « Isotopes Service International » restructuring was successfully completed at the end of 2018. In 2018, more than 11,2 million [...]

VBI Vaccines Appoints Blaine McKee to Board of Directors

16/01/2019 - 14:00

CAMBRIDGE, Mass., Jan. 16, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, [...]

Fibrocell to Present at Phacilitate Leaders World 2019

16/01/2019 - 14:00

EXTON, Pa., Jan. 16, 2019 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]

Cue Biopharma Announces Presentation Highlighting Immuno-STAT Platform and CUE-101 at the 2019 Keystone Symposia Conference

16/01/2019 - 14:00

Data Highlights the Potential of the CUE-100 Series to Selectively Deliver IL-2 to Tumor-relevant T cells while Mitigating the Risk Associated with Systemic IL-2 Activation CAMBRIDGE, Mass., Jan. 16, 2019 (GLOBE [...]

Sport Endurance to Reincorporate as Better Choice Company, Inc.

16/01/2019 - 14:00

BROOKLYN, N.Y., Jan. 16, 2019 (GLOBE NEWSWIRE) -- Sport Endurance, Inc. (OTCQB: SENZ) (the “Company”), today announced that it is reincorporating the Company in Delaware and renaming it as Better Choice Company, Inc. [...]

HomeCare Elite Honors 166 Amedisys Home Health Care Centers

16/01/2019 - 13:30

BATON ROUGE, La., Jan. 16, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and personal care company, today announced that 166 of its home health care centers [...]

Loop Industries Issues Letter to Shareholders

16/01/2019 - 13:30

MONTREAL, Jan. 16, 2019 (GLOBE NEWSWIRE) -- Loop Industries, Inc. (Nasdaq: LOOP) (“Loop” or the “Company”), a leading technology innovator in sustainable plastic, today issued the following open letter to shareholders: [...]

Aptinyx Reports Top-line Results from Phase 2 Clinical Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy

16/01/2019 - 13:27

NYX-2925 did not achieve statistically significant separation from placebo on primary endpoint Meaningful improvements on pain and other endpoints observed in subjects receiving 50 mg dose and in subjects not taking a [...]

THC Therapeutics Announces It Is Now a Reporting Company With The Securities and Exchange Commision (SEC)

16/01/2019 - 13:20

Company is Trading under Ticker Symbol THCT LAS VEGAS, Jan. 16, 2019 (GLOBE NEWSWIRE) -- THC Therapeutics, Inc. (OTC: THCT), a forward-thinking publicly traded Health and Wellness company in the cannabis industry that [...]

Resonant Inc. Presents Updated Company Presentation

16/01/2019 - 13:05

Provides Key Performance Indicators for 2019 GOLETA, Calif., Jan. 16, 2019 (GLOBE NEWSWIRE) -- Management from Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being [...]

With Danish Advancements, ICC Gears Up for Key Role in European Supply Chain -- CFN Media

16/01/2019 - 13:00

SEATTLE, Jan. 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

FDA Grants Cerecor’s Three Substrate Replacement Therapies Orphan Drug Designation

16/01/2019 - 12:30

BALTIMORE, Jan. 16, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of therapies for rare and orphan diseases in [...]

RavenQuest’s George Robinson Appointed Acting President & CEO of Bonify

16/01/2019 - 12:00

VANCOUVER, British Columbia, Jan. 16, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB, OTCQB: RVVQF, Frankfurt: 1IT) announces George Robinson, CEO, has been named interim [...]

Aino Health AB (publ): Aino Health signs agreement with global customer service company

16/01/2019 - 08:31

January 16 2019 Aino Health has signed an agreement regarding Aino HealthManager with a global company in customer service. The agreement encompasses more than 450 new licenses for Aino's SaaS solution HealthManager in [...]

Sales of Olainfarm Group in 2018 Exceed 123 Million

16/01/2019 - 08:19

Consolidated sales : December and twelve months Preliminary consolidated results of AS Olainfarm for December 2018 show that the sales of the Group have reached 11.1 million euros, which represents an increase by 10% [...]

Half-year report

16/01/2019 - 08:00

DXS INTERNATIONAL PLC HALF YEAR REPORT DXS International plc (“DXS” or “the Company”), the NEX Growth Market quoted healthcare information and clinical decision support systems provider today announces its half year [...]

VALNEVA Confirms FY 2018 Guidance and Provides Initial Product Sales Revenue Guidance for 2019

16/01/2019 - 07:16

Valneva Confirms FY 2018 Guidance and Provides Initial Product Sales Revenue Guidance for 2019 Following award of a new IXIARO ® supply contract with the U.S. Department of Defense, Valneva provides initial product [...]

VALNEVA confirme ses prévisions 2018 et publie ses premières perspectives de chiffre d'affaires pour 2019

16/01/2019 - 07:16

Valneva confirme ses prévisions 2018 et publie ses premières perspectives de chiffre d'affaires pour 2019 Suite à la signature du nouveau contrat IXIARO ® avec le Département de la Défense des Etats-Unis, Valneva est en [...]

VALNEVA Announces New $59 Million IXIARO® Supply Contract with US Government

16/01/2019 - 07:01

Valneva Announces New $59 Million IXIARO ® Supply Contract with US Government Saint Herblain (France), January 16, 2019 - Valneva SE ("Valneva" or "the Company"), a biotech company developing and commercializing [...]